interferon-beta (Nautilus)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinterferon-beta (Nautilus)
Drug Alias NameIFN-beta (Nautilus)improved IFN-beta (Nautilus)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNautilus Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNautilus Biotech
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A